Typical clinical uses
- Continuous vital-sign patches (ECG, SpO2, temp, respiration)
- Hospital-at-home and post-acute monitoring kits
- Chronic-disease RPM (CHF, COPD, hypertension)
- Maternal and pediatric RPM
- Medication adherence trackers
Cybersecurity for clinical wearables and RPM ecosystems.
Clinical wearables and RPM platforms span sensor, BLE link, mobile app, cloud, and EHR integration. We secure the full data path with a single coordinated engagement.
RPM and wearable devices stream PHI continuously over BLE and cellular into the cloud. High data volume, low device compute, and a large attack surface per patient - this is the segment where 'HIPAA-only' thinking most often misses FDA's premarket cyber expectations.
Successful RPM cybersecurity programs treat the device, gateway, cloud, and clinician dashboard as one system with a single SPDF and a single CVD process.
Typical clinical uses
Key data flows & integrations
Unauthenticated BLE pairing, fixed PINs, and unencrypted GATT services are the most common findings.
Telemetry brokers (MQTT, custom) need authenticated tenants, authorization at the topic level, and abuse limits.
Wearables need signed, atomic, rollback-safe OTA - and a CVD plan for the deployed fleet.
RPM and wearable devices stream PHI continuously over BLE and cellular into the cloud - high data volume, low device compute, and a large attack surface per patient.
Strong session crypto can blow battery targets - architecture has to balance both from day one.
Hundreds of thousands of devices per customer demands automation in SBOM monitoring, key rotation, and CVD response.
Many RPM teams come from a HIPAA mindset and miss FDA's explicit premarket cyber expectations.
EHR write-back and clinician dashboards add new authorization layers that have to be modeled and tested.
What FDA scrutinizes
Reviewers expect certificate pinning, secure boot on the gateway, and tamper-evident telemetry.
Hundreds of thousands of devices per customer demands automation in SBOM monitoring, key rotation, and CVD response.
EHR write-back and clinician dashboards add new authorization layers that have to be modeled and tested.
Only when you make a clinical claim and pursue clearance. As soon as you do, the full premarket cyber package applies.
Authenticated pairing (LE Secure Connections with numeric comparison or OOB) is the expectation. Just Works pairing is hard to defend in a threat model for a clinical device.
We verify signature validation, anti-rollback, atomic install, and recovery on a representative device, plus the cloud delivery path's authentication and integrity controls.
Yes when in scope - typically the FHIR or HL7 endpoint, its authentication (SMART on FHIR, mTLS, OAuth), and authorization model are tested as part of the wearable system.
We model and exercise battery-drain and DoS scenarios - they're a recognized safety-relevant cyber threat for wearables and need documented mitigations.
We perform cross-tenant authorization testing, key-scoping verification, and audit-trail review. Every cross-tenant access is treated as a critical finding.
BLE/Wi-Fi protocol testing, mobile companion app pen testing, and SBOM for connected RPM devices.
"Blue Goat Cyber's depth of expertise was impressive. We had no in-house cybersecurity experience, and their team guided us through every step of the FDA process. The penetration testing and SBOM testing were thorough and gave us complete confidence."
Cybersecurity for clinical wearables and RPM ecosystems.